NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CoreMap

CoreMap

Private
Burlington, MassachusettsHealthcare & Life Scienceshttps://coremapmedical.com/

Last Round

Series C

Jul 29, 2026

Total Funding Raised

$70.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

CoreMap is a medical device company that develops a diagnostic technology platform to identify the drivers of complex cardiac arrhythmias, such as atrial fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Clinical Trials, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

cardiac mappingatrial fibrillationAFibEP mappingarrhythmia mappingablation guidancepatient-specific ablationmicro-electrode cathetermedical signal processingarrhythmia driver mappinginvestigational devicemedical capital equipmentdisposable medical deviceinvestigational device exemptionIDE

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoreMap Comparables

Compare CoreMap with similar companies based on industry and business-model similarity.

CoreMap comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cortex
87%
EnChannel Medical
86%
Cortex, Inc.
81%

CoreMap Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 29, 2026
Early Stage VCJun 24, 2026
Series BFeb 9, 2022
Series A ExtensionFeb 9, 2022
Series ASep 17, 2020
Grant
Sep 8, 2020

Key People

Founding team and executive leadership

Sarah O. Kalil

Co-Founder, CEO

Founding Team

CoreMap Investors

Notable investors and investment history

CoreMap investors
InvestorRounds
OrbiMedSeries A
America's Seed FundGrant
UVM VenturesSeries A
National Science FoundationGrant
Qure VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 14, 33% of headcount.

  • Jul 13, 2026

    Open roles increased to 7, 4.2x the trailing average.

CoreMap Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CoreMap Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CoreMap's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range43
Year Founded2016
Last FundingJul 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.